Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Komarno – page 23

274 clinical trials in Komarno, Slovakia. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Komarno at a glance
274
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

274 trials in Komarno

Open in trial search

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Amgen Inc.

Study Comparing Darolutamide and Androgen Deprivation Therapy to Placebo and Androgen Deprivation Therapy in Men with High-Risk Prostate Cancer Recurrence

Registered drug
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Oesophageal carcinoma

Not recruiting

Study on the Effectiveness and Safety of Pembrolizumab, Lenvatinib, and Chemotherapy for Patients with Metastatic Esophageal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Merck Sharp & Dohme LLC

Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen Cilag International

Study of RO7247669 and Nab-Paclitaxel vs. Pembrolizumab and Nab-Paclitaxel for Patients with Untreated, PD-L1 Positive, Advanced Triple-Negative Breast Cancer

Registered drugNo placebo
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Study Comparing MK-1308A and Pembrolizumab for Patients with Advanced Colorectal Cancer with High Microsatellite Instability or Mismatch Repair Deficiency

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Dostarlimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Breast cancer+1

Not recruiting

Study of PF-07220060 and Letrozole for Postmenopausal Women with HR-Positive, HER2-Negative Breast Cancer

Registered drugNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Letrozole
  • Sponsor:Pfizer Inc.

Major depression

Not recruiting

Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Colitis ulcerative

Not recruiting

Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Komarno

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on non-small cell lung cancer and advanced breast cancer treatments, evaluating new therapeutic combinations and targeted approaches.

  • Breast Cancer Studies
  • Lung Cancer Therapies
  • Targeted Treatment Combinations

Multiple studies investigating hormone receptor-positive and HER2-negative breast cancer treatments with novel drug combinations.

02 Cardiovascular Medicine

Research centered on preventing and treating cardiovascular diseases, including studies on stroke prevention and innovative treatments for major cardiovascular events.

  • Stroke Prevention
  • Lipoprotein Management
  • Cardiovascular Risk Reduction

Trials evaluating new compounds for reducing cardiovascular events and improving patient outcomes.

03 Women's Health

Studies examining new approaches in contraceptive medicine and reproductive health, including novel delivery systems and long-term efficacy evaluations.

  • Contraceptive Solutions
  • Reproductive Health
  • Long-term Safety Studies

Clinical research focusing on innovative contraceptive methods and their safety profiles.

04 Dermatology

Research investigating treatments for chronic spontaneous urticaria, examining long-term efficacy and safety of new therapeutic options.

  • Urticaria Management
  • Long-term Treatment Effects
  • Patient Tolerance Studies

Evaluating advanced treatments for chronic skin conditions with focus on sustained symptom control.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.